$85.39
-0.320 (-0.373%)
At Close: Jul 31, 2026
ProShare Advisors LLC Sells 85,491 Shares of Medtronic PLC $MDT
03:32am, Monday, 09'th Feb 2026
ProShare Advisors LLC trimmed its stake in Medtronic PLC (NYSE: MDT) by 4.0% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,053,459
What is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill.
12:09pm, Sunday, 08'th Feb 2026
High-yielding dividend growth stocks tend to deliver the best long-term performance. Johnson & Johnson and Medtronic both offer dividend yields that are well above the S&P 500.
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
09:30pm, Saturday, 07'th Feb 2026
Eli Lilly's stock price rose sharply as demand for its GLP-1 drugs increased. Novo Nordisk is the second fiddle in GLP-1 drugs, but its GLP-1 pill is seeing strong demand.
Richard Pzena's Strategic Moves: A Closer Look at PPG Industries Inc.
05:02pm, Friday, 06'th Feb 2026
Insights from the Fourth Quarter 2025 13F Filing Richard Pzena (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2025, providing
Ashton Thomas Private Wealth LLC Buys 7,930 Shares of Medtronic PLC $MDT
04:47am, Friday, 06'th Feb 2026
Ashton Thomas Private Wealth LLC increased its stake in shares of Medtronic PLC (NYSE: MDT) by 31.2% during the undefined quarter, according to its most recent Form 13F filing with the Securities and
Applied Medical Prevails in Antitrust Jury Trial Against Medtronic
07:11pm, Thursday, 05'th Feb 2026
RANCHO SANTA MARGARITA, Calif.--(BUSINESS WIRE)--Applied Medical Prevails in Antitrust Jury Trial Against Medtronic.
Medtronic owes $382 million to medical device rival in antitrust lawsuit, US jury says
05:43pm, Thursday, 05'th Feb 2026
Medical technology company Medtronic owes rival device manufacturer Applied Medical Resources $382 million in damages for unlawfully monopolizing the market for blood-vessel sealing surgical devices,
2 Healthcare Dividend Stocks That are Just What the Doctor Ordered
05:35pm, Tuesday, 03'rd Feb 2026
AbbVie has successfully hurdled the Humira patent cliff. Medtronic is seeing new growth from smart devices.
Medical device maker Medtronic to buy CathWorks in up to $585 million deal
09:06am, Tuesday, 03'rd Feb 2026
Medtronic said on Tuesday it would buy privately held CathWorks in a deal valued at up to $585 million, as it looks to bolster its heart devices portfolio by adding a new diagnostic tool that could im
Medtronic advances its innovation strategy with intent to acquire CathWorks
08:17am, Tuesday, 03'rd Feb 2026
Deal demonstrates Medtronic's commitment to expanding pipeline through strategic investments and targeted acquisitions Exercising option to acquire will bolster Medtronic's interventional cardiology
Pre-Market Stock Futures: Futures are trading higher after a strong bounce-back Monday, with all major indices ending the day higher, as we started February on a winning note. Investors were able to l
Medtronic Diabetes expands access to full-stack insulin delivery solutions with Medicare access and new FDA clearances
09:17am, Monday, 02'nd Feb 2026
GALWAY, Ireland, Feb. 2, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced three significant U.S. milestones that expand access, choice, and flexi
Jones Financial Companies Lllp Acquires 85,715 Shares of Medtronic PLC $MDT
05:15am, Monday, 02'nd Feb 2026
Jones Financial Companies Lllp boosted its holdings in shares of Medtronic PLC (NYSE: MDT) by 10.7% in the third quarter, according to its most recent filing with the Securities and Exchange Commissio
Allied Investment Advisors LLC Boosts Holdings in Medtronic PLC $MDT
04:07am, Monday, 02'nd Feb 2026
Allied Investment Advisors LLC grew its holdings in Medtronic PLC (NYSE: MDT) by 5.6% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commis
Medtronic PLC (NYSE:MDT) Given Average Rating of “Moderate Buy” by Brokerages
01:43am, Monday, 02'nd Feb 2026
Medtronic PLC (NYSE: MDT - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the twenty-six brokerages that are currently covering the firm, Marketbeat reports. Eleve
Sign In
Buy MDT